These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8470258

  • 21. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Lui WY, Chang FY, Lee SD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [Abstract] [Full Text] [Related]

  • 22. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
    Santos L, Alves R, Macario F, Parada B, Campos M, Mota A.
    Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
    [Abstract] [Full Text] [Related]

  • 23. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Pardo M, Carreño V.
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [Abstract] [Full Text] [Related]

  • 24. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 25. [Liver transplantation in patients with chronic viral hepatitis].
    Moreno R, Berenguer M.
    Rev Gastroenterol Mex; 2005 Apr; 70(2):180-91. PubMed ID: 16167494
    [Abstract] [Full Text] [Related]

  • 26. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W, Al-Nakib W.
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [Abstract] [Full Text] [Related]

  • 27. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V, Marzano A, Zamboni F, Barbui A, Franchello A, Gaia S, Marchiaro G, Salizzoni M, Rizzetto M.
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [Abstract] [Full Text] [Related]

  • 28. Posttransplantation: future therapies.
    Peters MG, Shouval D, Bonham A, Vierling JM, Lok AS.
    Semin Liver Dis; 2000 Mar; 20 Suppl 1():19-24. PubMed ID: 10895440
    [Abstract] [Full Text] [Related]

  • 29. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.
    Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U.
    Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076
    [Abstract] [Full Text] [Related]

  • 30. Outcomes of hepatitis B virus recurrence after liver transplantation.
    Han YS, Lee SK, Joh JW, Kim SJ, Kwon CH, Park JW, Kim DJ, Park JB.
    Transplant Proc; 2006 Sep; 38(7):2123-4. PubMed ID: 16980019
    [Abstract] [Full Text] [Related]

  • 31. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL.
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [Abstract] [Full Text] [Related]

  • 32. Influence of backward bifurcation in a model of hepatitis B and C viruses.
    Qesmi R, Wu J, Wu J, Heffernan JM.
    Math Biosci; 2010 Apr; 224(2):118-25. PubMed ID: 20085774
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis C in liver transplant recipients.
    Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1504-5. PubMed ID: 1846471
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation.
    Liu LU, Schiano TD.
    Expert Rev Clin Immunol; 2007 Mar; 3(2):125-30. PubMed ID: 20477101
    [Abstract] [Full Text] [Related]

  • 35. [Hepatitis virus infection and bone marrow transplantation].
    Huang XJ, Guo NL, Zheng R.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr; 16(3):166-70. PubMed ID: 7648643
    [Abstract] [Full Text] [Related]

  • 36. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation.
    Féray C, Gigou M, Samuel D, Ducot B, Maisonneuve P, Reynès M, Bismuth A, Bismuth H.
    Ann Intern Med; 1998 May 15; 128(10):810-6. PubMed ID: 9599192
    [Abstract] [Full Text] [Related]

  • 37. Hepatitis B and hepatitis C viruses in liver transplantation.
    Curry MP.
    Transplantation; 2004 Oct 15; 78(7):955-63. PubMed ID: 15480158
    [Abstract] [Full Text] [Related]

  • 38. [Viral hepatitides infections in transplant recipients].
    Castells L.
    Enferm Infecc Microbiol Clin; 2006 Feb 15; 24(2):118-28. PubMed ID: 16545319
    [Abstract] [Full Text] [Related]

  • 39. Management of recurrent viral hepatitis B and C after liver transplantation.
    Montalbano M, Neff GW.
    Curr Gastroenterol Rep; 2006 Feb 15; 8(1):60-6. PubMed ID: 16510036
    [Abstract] [Full Text] [Related]

  • 40. Liver transplantation in virus-induced chronic liver disease.
    Colantoni A, De Maria N, Fagiuoli S, Van Thiel DH.
    Baillieres Clin Gastroenterol; 1996 Jul 15; 10(2):375-88. PubMed ID: 8864038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.